miR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1
Minghui Cao(Nanjing University), Dongxia Hou(China Pharmaceutical University), Hongwei Liang(Nanjing University), Fei Gong(China Pharmaceutical University), Yilei Wang(Nanjing University), Xin Yan(Tianjin Medical University Cancer Institute and Hospital), Xiaohong Jiang(Nanjing University), Chen Wang(China Pharmaceutical University), Junfeng Zhang(China Pharmaceutical University), Ke Zen(Nanjing University), Chen‐Yu Zhang(China Pharmaceutical University), Xi Chen(China Pharmaceutical University)
Cited by 110